An important step toward better understanding neural circuit function was recently made possible thanks to the breakthrough development of optogenetic tools. In this approach, the microbial opsin genes [most notable, Channelrhodopsin (ChR-2) and halorhodopsin (NpHR)] are expressed in neurons either by viral transduction or transgenesis. Neurons expressing opsin can then be activated or inhibited by light at specific wavelengths. Due to its great spatiotemporal resolution, optogenetics is able to functionally dissect brain circuits, as well as to offer new insights into the causal relationship between brain activity and behavior and, possibly, lead to therapies for neuropsychiatric diseases. However, due to the limited tissue penetration of light at the wavelengths necessary to activate optogenetic constructs, the stimulation of behaving animals has to rely on chronically implanted, fiber-optics or mounted LEDs to deliver light into deep brain tissues. Although this method is very useful and has yielded a wealth of information about brain circuits, stimulation via fiber-optics also has important limitations, particularly in regard to chronic stimulation in awake animals. To address this challenging issue, we propose to develop a wireless optogenetic strategy to remotely activate opsins in vivo using a relay nano- illuminator. This approach is buil upon key technologic advances recently made in our laboratory in lanthanide-doped upconversion nanoparticles (UCNPs), a new generation of nanoparticles with unexpected properties. The most significant advantage of UCNPs is their unnatural inverse excitation and emission profiles;i.e., they are excited using biocompatible, low power, deep tissue-penetrant, near infrared radiation that is effectively converted to a higher energy output emission at various shorter wavelengths, including visible light for activation of opsins. We propose two specific aims.
For Aim 1, we will characterize the ability of UNCPs to act as "relay illuminators" in vitro and in vivo. We will initially focus on the first generation of UCNP nanoparticles (CaF2 coated core/shell UCNP) that our preliminary experiments have demonstrated to exhibit robust emission from deep brain tissue.
In Aim2, we will develop novel combinatorial synthesis to enhance optogenetic performance of lanthanide-doped UCNPs. This new strategy will overcome many of the limitations of current fiber-optic based approaches, and will enable new applications in both fundamental science and human health.
Optogenetic approaches are having significant impact on neuroscience, enabling deconstruction of previously inaccessible brain circuits, and offering new insights into the causal relationship between circuit activity, behavior, and neuropsychiatric diseases. In current optogenetic experiments, light locally delivered to the brain region of interest by fiber-optics modulates the activity of neurons expressing microbial opsins (most notably, ChR2 and NpHR). Unfortunately, stimulation via fiber-optics is an important limitation for the applicability of optogenetics for chronic stimulation in awake animals. Our goal is to develop a nanoilluminator relay to eliminate the need of implanting optical fibers to enable true remote wireless control of neuronal cell function.
|Punjabi, Amol; Wu, Xiang; Tokatli-Apollon, Amira et al. (2014) Amplifying the red-emission of upconverting nanoparticles for biocompatible clinically used prodrug-induced photodynamic therapy. ACS Nano 8:10621-30|
|Yang, Limin; Li, Ruonan; Kaneko, Takuya et al. (2014) Trim9 regulates activity-dependent fine-scale topography in Drosophila. Curr Biol 24:1024-30|